Business · 08/06/2011Updated: 10/17/2026 · 1 min read
Bristol-Myers Squibb Co. et al. Withdraw FDA Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of 70 new drug applications and 97 abbreviated new drug applications from multiple applicants, following written notifications from the applicants that the drug products are no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →